Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

That’s when the same type of cancer comes back after you have completed treatment and gone into remission. But some cancers, such as ovarian cancer, also raise your risk for developing a ...

While breast cancer is rare in men, the disease can affect men too ... Additional things to look for are breast discoloration, scaly or pitted skin, and clear or bloody nipple discharge. Cells with ...

The ovarian reserve is the number of healthy eggs ... College of Public Health and program coordinator of the Fire Fighter Cancer Cohort Study's Women Firefighter Study. The paper "Evaluating ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - like these popular medications.

The ChemoFx® treatment selection marker ... cancer cases are diagnosed each year, the most frequent of which are endometrial, cervical and ovarian. “Of the approximately 150,000 live cell ...

diabetes or breast cancer patients on tamoxifen, would certainly benefit from the advent of a reliable serum-marker panel to aid early diagnosis. Noninvasive means for detecting EC may improve ...